⌘K

Home/Filings/4/0001493152-23-000408

4//SEC Filing

Singh Vanila 4

Accession 0001493152-23-000408

CIK 0001708331other

View on SEC.gov Company Profile

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 8:30 PM ET

Size

5.2 KB

Accession

0001493152-23-000408

Insider Transaction Report

Form 4

Period: 2023-01-01

Virpax Pharmaceuticals, Inc.VRPX

Director

Transactions

Award
Stock Option (right to buy)
2023-01-01+15,000→ 15,000 total
Exercise: $0.62From: 2024-01-01Exp: 2033-01-01→ Common Stock (15,000 underlying)

Documents

1 file

4
ownership.xmlPrimary

Issuer

Virpax Pharmaceuticals, Inc.

CIK 0001708331

Entity typeother

Related Parties

1

filerCIK 0001795397

Filing Metadata

Form type: 4
Filed: Jan 3, 7:00 PM ET
Accepted: Jan 4, 8:30 PM ET
Size: 5.2 KB

View on SEC.gov